Neos Therapeutics, Inc. (NEOS): Price and Financial Metrics
GET POWR RATINGS... FREE!
NEOS Stock Summary
- NEOS has a market capitalization of $57,220,154 -- more than approximately merely 10.36% of US stocks.
- The capital turnover (annual revenue relative to shareholder's equity) for NEOS is -2.77 -- better than just 3.04% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at -5.48 for Neos Therapeutics Inc; that's greater than it is for merely 2.92% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Neos Therapeutics Inc are TELA, CRY, ADMS, ADMA, and VAPO.
- NEOS's SEC filings can be seen here. And to visit Neos Therapeutics Inc's official web site, go to www.neostx.com.
NEOS Stock Price Chart Interactive Chart >
NEOS Price/Volume Stats
|Current price||$1.15||52-week high||$1.68|
|Prev. close||$1.18||52-week low||$0.45|
|Day high||$1.18||Avg. volume||7,441,074|
|50-day MA||$0.91||Dividend yield||N/A|
|200-day MA||$0.73||Market Cap||57.22M|
Neos Therapeutics, Inc. (NEOS) Company Bio
Neos Therapeutics develops, manufactures, and commercializes products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technologies. The company was founded in 2008 and is based in Grand Prairie, Texas.
NEOS Latest News Stream
|Loading, please wait...|
NEOS Latest Social Stream
View Full NEOS Social Stream
Latest NEOS News From Around the Web
Below are the latest news stories about Neos Therapeutics Inc that investors may wish to consider to help them evaluate NEOS as an investment opportunity.
The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 18) AngioDynamics, Inc. (NASDAQ: ANGO ) Anixa Biosciences, Inc. (NASDAQ: ANIX ) ENDRA Life Sciences Inc. (NASDAQ: NDRA ) (announced a collaboration with Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA ) for NASH studies) Harvard Bioscience, Inc. (NASDAQ: HBIO ) Neos Therapeutics, Inc. (NASDAQ: NEOS ) (reacted to the shareholder meeting held to vote on the proposal to merge with Aytu BioScience, Inc. (NASDAQ: AYTU )) NuVasive, Inc. (NASDAQ: NUVA ) SI-BONE, Inc. (NASDAQ: SIBN ) Sierra Oncology, Inc. (NASDAQ: SRRA ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) Terns Pharmaceuticals, Inc. (NASDAQ: TERN ) Varian Medical Systems, Inc. (NASDAQ: VAR ) Veric...
Headquartered in Grand Prairie, TEXAS, Neos Therapeutics Inc (NEOS) is a pharmaceutical company, develops, manufactures, and commercializes products for the
NEOS stock is screaming for the top as investors await the results of a special meeting surrounding a potential merger with AYTU.
Aytu Biosciences Inc. (NASDAQ: AYTU ) shares gapped up Thursday morning. The price jump is speculatively from the meetings the company is having about the proposed merger with Neos Therapeutics Inc. (NASDAQ: NEOS ). Aytu Short Term Chart Analysis: The 5-minute chart above shows the stock has built higher lows throughout the week and last up to a resistance level of $10. The stock broke out of the resistance level and is now falling back to support. The stock could test the potential support and find a … Full story available on Benzinga.com
Gainers Neos Therapeutics, Inc. (NASDAQ: NEOS) shares rose 58.6% to $1.84 in pre-market trading. Upstart Holdings, Inc. (NASDAQ: UPST) rose 42.6% to $86.71 …
NEOS Price Returns